Alessandro Felici*, Ferdinando Segala, Petra Luggin, Giuliano Parolin and Albert March
In recent years, we have witnessed significant developments in the intravenous drug administration sector. This is especially true in the case of patients whose therapy is expected to last longer than three days, and the infusion still meets the criteria for a peripheral line. In this clinical situation we have the availability of midline catheters, devices able to remain in place for the duration of therapy for mid-long term IV therapy, both for in and out of hospital therapies and both for continuous and discontinuous therapies.